Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 39

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 39
---
 options held by Mr. Massaro that are exercisable within 60 days of March 21, 2025 and 559 RSUs held by Mr. Massaro that vest within 60 days of March 21, 2025. (16) Includes 3,572 shares of common stock subject to options held by Dr. Thompson that are exercisable within 60 days of March 21, 2025 and 559 RSUs held by Dr. Thompson that vest within 60 days of March 21, 2025. (17) Includes 8,252 shares of common stock subject to options held by Mr. Wallman that are exercisable within 60 days of March 21, 2025 and 1,019 RSUs held by Mr. Wallman that vest within 60 days of March 21, 2025. (18) Includes 8,252 shares of common stock subject to options held by Ms. Wilson that are exercisable within 60 days of March 21, 2025 and 559 RSUs held by Ms. Wilson that vest within 60 days of March 21, 2025. 34

(19) Includes 180,553 shares of common stock subject to options exercisable within 60 days of March 21, 2025. None of the 621,783 shares reflected have been pledged as security. Equity Compensation Plan Information

| Plan Category                                              
 ​                                                          
 Equity compensation plan approved by security holders:     | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Number ofsecurities tobe issuedupon exerciseof outstandingoptions, warrantsand rights 
 (a)                                                                                   
 ​                                                                                     | ​ |          ​ | ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Weightedaverageexercise priceof outstandingoptions,warrantsand rights 
 (b)                                                                   
 ​                                                                     | ​ |      ​ | ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Number of securitiesremaining available forfuture issuance underequity compensationplans (excludingsecurities reflected incolumn (a)) 
 (c)                                                                                                                                   
 ​                                                                                                                                     | ​ |            ​ | ​ | ​ 
 ​ 
 ​ |
|:-----------------------------------------------------------|:--|:--|:--------------------------------------------------------------------------------------|:--|-----------:|:--|:--|:--|:----------------------------------------------------------------------|:--|-------:|:--|:--|:--|:--------------------------------------------------------------------------------------------------------------------------------------|:--|-------------:|:--